Published in J Inflamm Res on September 28, 2017
The JAK-STAT signaling pathway: input and output integration. J Immunol (2007) 4.92
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. Blood (2010) 4.33
The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets (2007) 2.17
The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol (2009) 1.47
Signaling by STATs. Arthritis Res Ther (2004) 1.35
Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/I2. Arthritis Rheum (2003) 1.35
Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Clin Cancer Res (1999) 1.32
Culture of immortalized chondrocytes and their use as models of chondrocyte function. Methods Mol Med (2004) 1.07
Proteoglycan production by immortalized human chondrocyte cell lines cultured under conditions that promote expression of the differentiated phenotype. Arch Biochem Biophys (2000) 1.04
Tocilizumab in the treatment of rheumatoid arthritis and beyond. Drug Des Devel Ther (2014) 0.97
Intracellular Signaling Pathways in Rheumatoid Arthritis. J Clin Cell Immunol (2013) 0.95
Monosodium Urate and Tumor Necrosis Factor-α Increase Apoptosis in Human Chondrocyte Cultures. Rheumatology (Sunnyvale) (2012) 0.88
IL-6 activates STAT5 in T cells. Cytokine (2012) 0.87
STAT1 is Constitutively Activated in the T/C28a2 Immortalized Juvenile Human Chondrocyte Line and Stimulated by IL-6 Plus Soluble IL-6R. J Clin Cell Immunol (2015) 0.84
Protein kinase small molecule inhibitors for rheumatoid arthritis: Medicinal chemistry/clinical perspectives. World J Orthop (2014) 0.80
U0126, an Inhibitor of MEK1/2, Increases Tumor Necrosis Factor-α-Induced Apoptosis, but not Interleukin-6 Induced Apoptosis in C-28/I2 Human Chondrocytes. J Autoimmune Disord (2015) 0.79
Recent advances in neutralizing the IL-6 pathway in arthritis. Open Access Rheumatol (2009) 0.79